- Home
- RGF vs BMRA Comparison
RGF vs BMRA Comparison
Compare RGF & BMRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RGF
- BMRA
- Stock Information
- Founded
- RGF 2016
- BMRA 1971
- Country
- RGF United States
- BMRA United States
- Employees
- RGF N/A
- BMRA N/A
- Industry
- RGF Packaged Foods
- BMRA Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- RGF Consumer Staples
- BMRA Health Care
- Exchange
- RGF Nasdaq
- BMRA Nasdaq
- Market Cap
- RGF 8.3M
- BMRA 7.4M
- IPO Year
- RGF 2021
- BMRA N/A
- Fundamental
- Price
- RGF $0.36
- BMRA $0.32
- Analyst Decision
- RGF Hold
- BMRA
- Analyst Count
- RGF 1
- BMRA 0
- Target Price
- RGF $0.50
- BMRA N/A
- AVG Volume (30 Days)
- RGF 1.2M
- BMRA 68.2K
- Earning Date
- RGF 11-08-2024
- BMRA 10-15-2024
- Dividend Yield
- RGF N/A
- BMRA N/A
- EPS Growth
- RGF N/A
- BMRA N/A
- EPS
- RGF N/A
- BMRA N/A
- Revenue
- RGF $156,379,000.00
- BMRA $5,509,000.00
- Revenue This Year
- RGF $23.67
- BMRA N/A
- Revenue Next Year
- RGF N/A
- BMRA N/A
- P/E Ratio
- RGF N/A
- BMRA N/A
- Revenue Growth
- RGF 18.88
- BMRA 1.74
- 52 Week Low
- RGF $0.21
- BMRA $0.24
- 52 Week High
- RGF $2.75
- BMRA $2.13
- Technical
- Relative Strength Index (RSI)
- RGF 45.74
- BMRA 47.45
- Support Level
- RGF $0.33
- BMRA $0.28
- Resistance Level
- RGF $0.40
- BMRA $0.35
- Average True Range (ATR)
- RGF 0.04
- BMRA 0.03
- MACD
- RGF 0.00
- BMRA 0.00
- Stochastic Oscillator
- RGF 56.82
- BMRA 38.50
About RGF The Real Good Food Company Inc.
The Real Good Food Company Inc is an high-growth, branded, health- and wellness-focused frozen food company. It develops, markets, and manufactures delicious and convenient comfort foods designed to be high in protein, low in sugar, and made from gluten- and grain-free ingredients that are intended to be sold in the health and wellness segment of the frozen food category. All of its revenue is derived from the United States.
About BMRA Biomerica Inc.
Biomerica Inc is engaged in the development, manufacturing, and marketing of medical diagnostic products designed for the early detection and monitoring of chronic diseases and medical conditions. The company focuses on products for gastrointestinal diseases, food intolerances, diabetes, and certain esoteric tests. It operates in one segment namely, the design, development, marketing and sales of diagnostic kits. The majority of the company's revenue is earned from the Europe market.